Related Experiment Video
Updated: May 16, 2025

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelial dysfunction in patients with type 2 diabetes: the truth is in the blood
Sarah Costantino1,2, Shafeeq A Mohammed1, Francesco Paneni1,2
1Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Insights
Red blood cells (RBCs) from diabetic patients release extracellular vesicles (EVs) that impair blood vessel function. These RBC-derived EVs transfer the enzyme arginase-1, causing oxidative stress and endothelial dysfunction.
Area of Science:
- Vascular Biology
- Diabetology
- Cellular Mechanisms
Background:
- Endothelial dysfunction is a key factor in diabetic vascular complications.
- Red blood cells (RBCs) play a significant role in this dysfunction, but the exact mechanisms are not fully understood.
Purpose of the Study:
- To elucidate the mechanisms by which RBCs contribute to endothelial dysfunction in diabetes.
- To identify the role of extracellular vesicles (EVs) in mediating the detrimental effects of RBCs on the endothelium.
Main Methods:
- Investigated extracellular vesicles (EVs) derived from RBCs (RBC-EVs) of patients with diabetes.
- Assessed the uptake of RBC-EVs by endothelial cells.
- Evaluated the impact of RBC-EVs on endothelium-dependent relaxation.
- Analyzed the transfer of arginase-1 (Arg1) from RBC-EVs to endothelial cells.
Main Results:
- RBC-EVs from diabetic patients were internalized by endothelial cells.
- EV-mediated transfer of arginase-1 (Arg1) from RBCs to endothelial cells was identified as a key mechanism.
- This transfer led to impaired endothelium-dependent relaxation and increased vascular oxidative stress.
Conclusions:
- Extracellular vesicles (EVs) from diabetic red blood cells (RBCs) mediate endothelial dysfunction.
- The prooxidant enzyme arginase-1 (Arg1) transfer via RBC-EVs contributes to vascular oxidative stress in diabetes.
- Targeting RBC-EV uptake presents a potential strategy for preventing diabetic vascular complications.
Abstract:
Endothelial dysfunction remains a cornerstone of diabetic vascular complications. RBCs emerge as pivotal players in endothelial dysfunction, yet the underlying mechanisms remain elusive. In this issue of the JCI, Collado et al. show that the detrimental action of RBCs on the endothelium is mediated by extracellular vesicles (EVs). EVs derived from RBCs (RBC-EVs) of patients with diabetes were taken up by the endothelium and were able to impair endothelium-dependent relaxation via an EV-mediated transfer of the prooxidant enzyme arginase-1 (Arg1) from RBCs to endothelial cells. These findings reveal events implicated in vascular oxidative stress and set the stage for personalized approaches preventing RBC-EVs' uptake by the endothelium.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer

